St. Jude Begins EnligHTN II Trial

St. Jude Medical Inc. (STJ - Analyst Report) has initiated the EnligHTN II trail with the enrollment of the first patient to further evaluate its renal denervation technology in treating uncontrolled hypertension. This follows the successful EnligHTN I trial presented at the 2012 American Heart Association (AHA) meeting.
Zack’s